Popularity #4,027Earnings are out
TLSA · NASDAQ · Biotechnology

Tiziana Life Sciences (ADR) (TLSA)

Develops intranasal anti-CD3 immunotherapy for neuroinflammatory and neurodegenerative diseases.

$1.03
vs last close+0.14 (+15.18%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Dec '23May '24Jun '24Oct '24Jul '25Oct '25May '26Sep '26
Reported−$0.17−$0.18−$0.18−$0.18−$0.06−$0.10−$0.22−$0.08
Estimate−$0.07−$0.09−$0.08
Surprise−35.4%−143.0%−1.3%

RevenueReportedEstimate

Dec '23May '24Jun '24Oct '24Jul '25Oct '25May '26Sep '26
Reported
Estimate
Surprise

History

Date / PeriodEstimateReportedSurprise
Sep 2026−$0.08−$0.08−1.3%
May 2026−$0.09−$0.22−143.0%
Oct 2025−$0.07−$0.10−35.4%
Jul 2025−$0.06
Oct 2024
Jun 2024
May 2024
Dec 2023
Oct 2023
Apr 2023
Dec 2022
Aug 2022
Sep 2021
May 2021
Sep 2020
Jun 2020
Sep 2019
Apr 2019
Nov 2018
Dec 2017
Jun 2017
Dec 2016
Jun 2016
Dec 2015
Jun 2015
Dec 2014
Jun 2014
Dec 2010
Jun 2010
Dec 2009
Jun 2009
Dec 2008
Jun 2008
Dec 2007
Jun 2007
Dec 2006
Jun 2006
Dec 2005
Jun 2005
Dec 2004
Jun 2004
Dec 2003
Jun 2003
Dec 2002
Jun 2002
Dec 2001

The latest year is open to everyone — the 42 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Sep 18, 2026−$0.08−$0.08−1.3%−6.6%
May 1, 2026−$0.09−$0.22−143.0%+4.7%
Oct 3, 2025−$0.07−$0.10−35.4%0.0%
Jul 8, 2025−$0.06+1.3%
Oct 18, 2024
Jun 30, 2024
May 10, 2024
Dec 26, 2023
Oct 3, 2023
Apr 26, 2023
Dec 27, 2022
Aug 19, 2022
Sep 24, 2021
May 18, 2021
Sep 30, 2020
Jun 17, 2020
Sep 30, 2019
Apr 4, 2019
Nov 21, 2018
Dec 31, 2017
Jun 30, 2017
Dec 31, 2016
Jun 30, 2016
Dec 31, 2015
Jun 30, 2015
Dec 31, 2014
Jun 30, 2014
Dec 31, 2010
Jun 30, 2010
Dec 31, 2009
Jun 30, 2009
Dec 31, 2008
Jun 30, 2008
Dec 31, 2007
Jun 30, 2007
Dec 31, 2006
Jun 30, 2006
Dec 31, 2005
Jun 30, 2005
Dec 31, 2004
Jun 30, 2004
Dec 31, 2003
Jun 30, 2003
Dec 31, 2002
Jun 30, 2002
Dec 31, 2001

The latest year is open to everyone — the 42 quarters behind it read with an account.